GEODE CAPITAL MANAGEMENT, LLC
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in CRNX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$102,068,026
+$11,966,715 QoQ
Shares Held
2,727,633
+10.0% QoQ
Ownership
2.57%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#10
of 264 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. CRNX ranks #47 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in CRNX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $102,068,026 | 2,727,633 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $90,101,311 | 2,480,763 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $104,394,472 | 2,242,631 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $94,913,269 | 2,278,830 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $63,655,226 | 2,213,325 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $73,483,858 | 2,190,932 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $107,313,739 | 2,098,841 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $94,439,595 | 1,848,133 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $75,174,953 | 1,678,387 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $65,599,674 | 1,401,403 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $48,128,069 | 1,352,672 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $37,760,104 | 1,269,674 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $17,794,569 | 987,490 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $15,335,051 | 954,860 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $16,858,509 | 921,230 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $17,343,985 | 883,095 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $15,869,993 | 850,938 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $16,251,450 | 740,385 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $19,851,146 | 698,738 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $10,945,936 | 519,997 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $9,591,275 | 508,821 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,767,191 | 377,434 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $4,536,379 | 321,501 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $4,885,545 | 311,777 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,546,130 | 316,560 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,970,079 | 134,019 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||